AD-Omics
PrivateCompany Overview
AD-Omics is a biotechnology company that provides precision medicine diagnostic offerings and personalized healthcare solutions using single-cell and multi-omics technologies.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Precision Medicine, Healthcare Analytics, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales, Government Contracts
AI Layer
Application
Keywords
single-cell multi-omicsprecision medicinesingle-cell analysisnext-generation sequencingNGSchronic disease managementgenomic servicesbioinformaticsCROpersonalized healthcarelongevity medicinelife science toolsclinical diagnosticshealthcare analyticstranscriptomicscellular heterogeneity
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AD-Omics Comparables
Compare AD-Omics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Novo Genomics | 82% | |
| G42 | 77% | |
| NoorDx | 76% | |
AD-Omics Funding Rounds
Historical fundraising activity
AD-Omics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AD-Omics's valuation, stock price, and market status.